The State Food and Drug Administration revised the instructions for Carbimazole tablets

On June 16, the State Food and Drug Administration issued an announcement on the revision of the instructions for carbimazole tablets

The marketing authorization holders of the above-mentioned drugs shall, in accordance with the "Administrative Measures on Drug Registration" and other relevant regulations, revise the instructions (see appendix) in accordance with the requirements of the corresponding annexes, and report to the provincial drug regulatory authority for record before September 8, 2021

If the revised content involves the label of a drug, it shall be revised together; the instructions and other content of the label shall be consistent with the original approved content

The provincial drug supervision and administration department shall supervise and urge the drug marketing license holders of the above-mentioned drugs in the administrative area to do the corresponding manual revision and label and manual replacement work as required, and strictly investigate and deal with violations of laws and regulations